Cytocare Formulations Private Limited - Company Profile

It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2007.
2007 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Cytocare Formulations Private Limited

Cytocare Formulations Private Limited, a active private limited company, was established on 25 July 2007 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232WB2007PTC117462. Registered under ROC Roc Kolkata I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Partha Pratim Ghosh (Director), Gopa Ghosh (Director). It holds no open charges and ₹2.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat: B, 1St Floor 70C, Sadananda Road, Kolkata, West Bengal, 700026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232WB2007PTC117462

  • Registration Number

    117462

  • Incorporation Date

    25 July 2007

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.00 M
  • Revenue Growth **** 68.22%
  • Profit Growth **** -764.59%
  • Ebitda **** -365.07%
  • Net Worth -32.46%
  • Total Assets **** 7.82%
Company report

Cytocare Formulations Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Cytocare Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cytocare Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Partha Pratim Ghosh Director 25 Jul 2007 Current
Gopa Ghosh Director 25 Jul 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cytocare Formulations.

Cytocare Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.22% increase. The company also saw a substantial fall in profitability, with a 764.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.46%.

Cytocare Formulations revenue growth over time
Cytocare Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 68.22%
*******
*******
*******
*******
Revenue from Operations
*******
 80.67%
*******
*******
*******
*******
Total Assets
*******
 7.82%
*******
*******
*******
*******
Profit or Loss
*******
 -764.59%
*******
*******
*******
*******
Net Worth
*******
 -32.46%
*******
*******
*******
*******
EBITDA
*******
 -365.07%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cytocare Formulations?

Unlock access to Cytocare Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹2,000,000.00

Charges Breakdown by Lending Institutions
  • Vijaya Bank : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
15 Feb 2012 Vijaya Bank ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cytocare Formulations?

Unlock and access historical data on people associated with Cytocare Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cytocare Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytocare Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cytocare Formulations
Recent Activity within the Organization
  • Annual General Meeting

    The activity Cytocare Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Cytocare Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I. was completed.

  • Charges

    A charge registered on 15 Feb 2012 via Charge ID 10345923 with Vijaya Bank was fully satisfied on 29 Jul 2017. was recorded as a recent event.

  • Charges

    A charge with Vijaya Bank amounted to Rs. 2.00 M with Charge ID 10345923 was registered on 15 Feb 2012. was recorded as a recent event.

  • Director Appointment

    Progress on Partha Pratim Ghosh was appointed as a Director was appointed as a Director on 25 Jul 2007 & has been associated with this company since 18 years 8 months . was documented.

  • Director Appointment

    Gopa Ghosh was appointed as a Director was appointed as a Director on 25 Jul 2007 & has been associated with this company since 18 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cytocare Formulations Private Limited?

The CIN of Cytocare Formulations Private Limited is U24232WB2007PTC117462.

Where is Cytocare Formulations Private Limited headquartered?

Cytocare Formulations Private Limited is headquartered at Flat: B, 1St Floor 70C, Sadananda Road, Kolkata, West Bengal, 700026.

When was Cytocare Formulations Private Limited incorporated?

Cytocare Formulations Private Limited was incorporated on 25 July 2007.

Who are the current directors of Cytocare Formulations Private Limited?

The current directors of Cytocare Formulations Private Limited are

What is the primary industry of Cytocare Formulations Private Limited?

The primary industry of Cytocare Formulations Private Limited is Trade.

Is Cytocare Formulations Private Limited a listed company?

Cytocare Formulations Private Limited is unlisted.

What is the capital structure of Cytocare Formulations Private Limited?

The authorized capital of Cytocare Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Cytocare Formulations Private Limited?

The compliance status of Cytocare Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available